Helius Therapeutics to Launch THC Medications in NZ

Dec.27.2022
Helius Therapeutics to Launch THC Medications in NZ
Helius Therapeutics to launch THC medication produced and cultivated in New Zealand, obtaining GMP certification.

Helius Therapeutics is set to release drugs containing THC soon, all grown and manufactured in New Zealand.


Earlier, the country's largest licensed medicinal marijuana company was awarded a Good Manufacturing Practice (GMP) certificate from MedSafe, allowing them to produce THC medication.


2022 is a pivotal year for Helius. Achieving these milestones will enable us to bring more New Zealand-grown and manufactured products to patients in New Zealand," said Carmen Doran, CEO of Helius Therapeutics.


Last week, we announced our GACP certification. Now, we have achieved GMP certification in an additional four processes at our spacious East Auckland factory. This progress demonstrates the team collaboration culture being established at Helius," she said.


In July 2021, Helius obtained their first GMP certification and pharmaceutical manufacturing license. Since then, they have become the first company in New Zealand to launch and offer products made and grown in New Zealand. They are now the first company in New Zealand to obtain GMP certification for THC drugs.


In 2018, Helius began a rigorous and complex journey to achieve GMP certification as a startup. With international recognition and the latest approval from MedSafe meeting European standards, known as EU-GMP, this 100% New Zealand company now has potential for future export opportunities.


The GMP certification process is very thorough, and rightfully so. As we are in the business of pharmaceuticals, we cannot afford to cut corners. Helius has assembled a team of leaders with international experience in both the pharmaceutical and medicinal cannabis industries, and we have successfully achieved this level of compliance," she said.


As a leader in New Zealand's newest industry, Helius has been working with regulatory bodies from the beginning to ensure patient safety.


Carmen Doran, CEO of Helius, has been appointed to the New Zealand Medical Cannabis Council. This organization seeks to support the local industry and provide high-quality export products for patients worldwide. Doran stated that Helius has established teams and facilities to improve patients' quality of life and is dedicated to this goal.


Helius is utilizing vertical integration from the factory to the patient. Its operations link variety breeding with yield optimization, precise extraction of high-value cannabinoids, next-generation drug development, GMP production, and academic and scientific partnerships.


This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.

Product | ELFBAR Launches New Disposable E-Cigarette with Curved Display, 40,000-Puff Capacity in Middle East
Product | ELFBAR Launches New Disposable E-Cigarette with Curved Display, 40,000-Puff Capacity in Middle East
ELFBAR has launched a new e-cigarette, the Elfbar Moonlight, with a curved screen that shows real-time e-liquid and battery levels. It holds 22ml of e-liquid and can deliver up to 40,000 puffs in ECO mode, or about 1,818 puffs per milliliter. The device is currently sold only in the Middle East for around $13.62.
May.19 by 2FIRSTS.ai
JTI Launches Limited Edition Ploom X Advanced in South Korea, Priced at Around $50
JTI Launches Limited Edition Ploom X Advanced in South Korea, Priced at Around $50
On July 1, JTI Korea launched the Ploom X Advanced Limited Edition Ora Ito Red, a red heat-not-burn device developed in collaboration with designer Ora Ito. The standalone device is priced at approximately $50.
Jul.01 by 2FIRSTS.ai
Indian Anti-Vape Group: Weak Enforcement of Vape Ban as Online and Black Market Sales Surge
Indian Anti-Vape Group: Weak Enforcement of Vape Ban as Online and Black Market Sales Surge
Indian medical experts and the group Mothers Against Vaping warn that e-cigarettes damage youth heart, lung, and mental health. Despite the 2019 ban, vaping products remain available via underground markets. They call on the government to tighten digital platform regulation and adopt stricter international controls.
Jul.08
Dutch Government Launches Anti-Vaping Campaign as Nearly 10% of 12-Year-Olds Report E-Cigarette Use
Dutch Government Launches Anti-Vaping Campaign as Nearly 10% of 12-Year-Olds Report E-Cigarette Use
A new study in the Netherlands shows that 10% of 12-year-olds have tried e-cigarettes, and nearly 40% of users aged 12 to 16 say they are addicted. In response, the Dutch government launched a “Say No to E-Cigarettes” awareness campaign on May 12.
May.13 by 2FIRSTS.ai
Philippines DTI Reports $740K in Illegal E-Cigarette Seizures and Removal of 100 Million Violation Records This Year
Philippines DTI Reports $740K in Illegal E-Cigarette Seizures and Removal of 100 Million Violation Records This Year
Between January and May 2025, the Philippine DTI seized $740,000 worth of illegal e-cigarettes from 88 unauthorized brands. Over 104 million online violations were removed, 628 businesses flagged, 385 legal notices issued, and 10 brands suspended.
May.28
Polish Customs Seize 2,000 Illegal E-Cigarettes Worth Around $50,000
Polish Customs Seize 2,000 Illegal E-Cigarettes Worth Around $50,000
Polish customs in Białystok have seized 2,000 disposable e-cigarettes lacking excise tax labels, with an estimated value of 200,000 złoty (around \$50,000). The products were found to exceed legal e-liquid volume limits and lacked ingredient information and health warning labels.
May.13 by 2FIRSTS.ai